265 related articles for article (PubMed ID: 25203519)
1. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study.
Forrest LF; Adams J; White M; Rubin G
Br J Cancer; 2014 Oct; 111(9):1843-51. PubMed ID: 25203519
[TBL] [Abstract][Full Text] [Related]
2. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.
Forrest LF; Adams J; Rubin G; White M
Thorax; 2015 Feb; 70(2):138-45. PubMed ID: 24923873
[TBL] [Abstract][Full Text] [Related]
3. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008.
Dalton SO; Frederiksen BL; Jacobsen E; Steding-Jessen M; Østerlind K; Schüz J; Osler M; Johansen C
Br J Cancer; 2011 Sep; 105(7):1042-8. PubMed ID: 21897390
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
Beckett P; Tata LJ; Hubbard RB
Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
[TBL] [Abstract][Full Text] [Related]
6. Timeliness of lung cancer care in Victoria: a retrospective cohort study.
Evans SM; Earnest A; Bower W; Senthuren M; McLaughlin P; Stirling R
Med J Aust; 2016 Feb; 204(2):75. PubMed ID: 26821108
[TBL] [Abstract][Full Text] [Related]
7. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
10. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
[TBL] [Abstract][Full Text] [Related]
11. Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.
Ezer N; Navasakulpong A; Schwartzman K; Ofiara L; Gonzalez AV
BMC Pulm Med; 2017 Dec; 17(1):178. PubMed ID: 29216855
[TBL] [Abstract][Full Text] [Related]
12. The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study.
Forrest LF; White M; Rubin G; Adams J
Br J Cancer; 2014 Jul; 111(3):608-18. PubMed ID: 24918815
[TBL] [Abstract][Full Text] [Related]
13. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
[TBL] [Abstract][Full Text] [Related]
14. Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.
Belot A; Fowler H; Njagi EN; Luque-Fernandez MA; Maringe C; Magadi W; Exarchakou A; Quaresma M; Turculet A; Peake MD; Navani N; Rachet B
Thorax; 2019 Jan; 74(1):51-59. PubMed ID: 30100577
[TBL] [Abstract][Full Text] [Related]
15. Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit.
Nartey Y; Stewart I; Khakwani A; Beattie V; Wilcock A; Woolhouse I; Beckett P; Hubbard RB; Tata LJ
Lung Cancer; 2020 Feb; 140():27-34. PubMed ID: 31846785
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Lung Cancer Mortality in a Referral Center.
Jamaati H; Baghaei P; Sharifianfard M; Emami H; Najmi K; Seifi S; Salimi B; Pourabdollah M; Kiani A; Hashemian M; Khosravi A
Asian Pac J Cancer Prev; 2016; 17(6):2877-81. PubMed ID: 27356706
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
[TBL] [Abstract][Full Text] [Related]
18. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
Kim YJ; Kim MJ; Cho YJ; Park JS; Kim JW; Chang H; Lee JO; Lee KW; Kim JH; Yoon HI; Bang SM; Lee JH; Lee CT; Lee JS
Med Oncol; 2014 Mar; 31(3):847. PubMed ID: 24448977
[TBL] [Abstract][Full Text] [Related]
19. The effect of a lung cancer care coordination program on timeliness of care.
Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
[TBL] [Abstract][Full Text] [Related]
20. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
